Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 6,069,900 | 4,991,100 | 4,131,200 | 3,551,100 | 3,084,100 |
| Cost of Goods | 553,500 | 394,500 | 374,300 | 454,200 | 258,300 |
| Gross Profit | 5,516,400 | 4,596,600 | 3,756,900 | 3,096,900 | 2,825,800 |
| Operating Expenses | 4,884,600 | 2,476,700 | 3,487,600 | 2,469,700 | 2,158,700 |
| Operating Income | 632,300 | 2,120,400 | 269,600 | 627,400 | 667,400 |
| Interest Expense | 104,700 | 77,800 | 98,200 | 98,400 | 96,900 |
| Other Income | 41,400 | 136,200 | 70,800 | 18,800 | 5,700 |
| Pre-tax Income | 569,000 | 2,178,800 | 242,200 | 547,800 | 576,200 |
| Income Tax | -34,400 | -225,500 | 164,600 | 104,500 | 176,800 |
| Net Income Continuous | 603,400 | 2,404,300 | 77,600 | 443,300 | 399,400 |
| Net Income | $603,400 | $2,404,300 | $77,600 | $443,300 | $399,400 |
| EPS Basic Total Ops | 2.74 | 10.77 | 0.35 | 1.98 | 1.78 |
| EPS Basic Continuous Ops | 2.74 | 10.77 | 0.35 | 1.98 | 1.78 |
| EPS Diluted Total Ops | 2.72 | 10.70 | 0.35 | 1.97 | 1.76 |
| EPS Diluted Continuous Ops | 2.72 | 10.70 | 0.35 | 1.97 | 1.76 |
| EPS Diluted Before Non-Recurring Items | 11.60 | 9.74 | 7.09 | 5.16 | 3.78 |
| EBITDA(a) | $3,015,000 | $2,497,200 | $688,400 | $1,124,100 | $1,063,800 |